Acuta Capital Partners, LLC Portfolio Holdings
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
Acuta Capital Partners, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $70.3 Million distributed in 39 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ocular Therapeutix, Inc with a value of $9.49M, Insmed Inc with a value of $7.24M, Crinetics Pharmaceuticals, Inc. with a value of $6.28M, Aadi Bioscience, Inc. with a value of $5.84M, and Revolution Medicines, Inc. with a value of $4.89M.
Examining the 13F form we can see an decrease of $28.4M in the current position value, from $98.8M to 70.3M.
Acuta Capital Partners, LLC is based out at Belmont, CA
Below you can find more details about Acuta Capital Partners, LLC portfolio as well as his latest detailed transactions.